Please login to the form below

Not currently logged in
Email:
Password:

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca
John Goddard Oxford Pharmascience

Oxford Pharmascience has bulked up its board with the appointment of industry veteran John Goddard as independent non-executive director.

Goddard has years of experience in pharma including a spell as head of group strategic planning and business development at AstraZeneca until his retirement in 2010.

He joined AZ after his former company Zeneca merged with Astra in 1999.

Oxford Pharmascience's chair Dave Norwood commented that Goddard's experience in the industry would be valuable as the company initiates the commercialisation of its drug pipeline.

10th March 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics